These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16082733)

  • 1. Abstracts of the European Drug Utilisation Research Group Conference, Coleraine, N. Ireland, 29 June-2 July 2005.
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14 Suppl 1():S1-38. PubMed ID: 16082733
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Utilization Research and Pharmacoepidemiology meeting. Utrecht, the Netherlands, 19 May 1995. Abstracts.
    Pharm World Sci; 1995 Sep; 17(5 Suppl I):11-7. PubMed ID: 8535379
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts on drug utilization research at seven International Conferences on Pharmacoepidemiology (ICPE): 1996-2002.
    Gorecka K; Hejdova M; Vander Stichele RH; Linhartova A; Kucera Z; Zemkova M; Vlcek J
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):621-2. PubMed ID: 15362085
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacovigilance--Current and Future Challenges. Abstracts of the International Society of Pharmacovigilance annual conference. Dublin, Ireland, 6-8 October 2004.
    Drug Saf; 2004; 27(12):911-77. PubMed ID: 15988859
    [No Abstract]   [Full Text] [Related]  

  • 5. The IMI PROTECT project: purpose, organizational structure, and procedures.
    Reynolds RF; Kurz X; de Groot MC; Schlienger RG; Grimaldi-Bensouda L; Tcherny-Lessenot S; Klungel OH
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():5-10. PubMed ID: 27038353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstracts of posters. Drug utilization research and pharmacoepidemiology meeting. Leiden (The Netherlands), 13 December 1991.
    Pharm Weekbl Sci; 1991 Dec; 13(6 Suppl K):K1-12. PubMed ID: 1749712
    [No Abstract]   [Full Text] [Related]  

  • 7. Abstracts of posters. Drug utilization research and pharmacoepidemiology meeting. Utrecht (The Netherlands), 27 September 1990.
    Pharm Weekbl Sci; 1990 Oct; 12(5 Suppl F):F1-6. PubMed ID: 2216671
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Utilization Research and Pharmacoepidemiology Meeting. Utrecht, The Netherlands, 27 November 1992. Abstracts.
    Pharm Weekbl Sci; 1992 Dec; 14(6 Suppl G):G1-7. PubMed ID: 1461711
    [No Abstract]   [Full Text] [Related]  

  • 9. Abstracts of the united kingdom environmental mutagen society 23(rd) annual general meeting, june 23-25, university of ulster, coleraine, northern ireland, UK.
    Mutagenesis; 1999 Nov; 14(6):639-56. PubMed ID: 10567040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacoepidemiology. I].
    Kolár J
    Ceska Slov Farm; 1996 Nov; 45(6):275-8. PubMed ID: 8998608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abstracts of the 9th European Cytogenetics Conference. June 29-July 2, 2013. Dublin, Ireland.
    Chromosome Res; 2013 Jun; 21 Suppl 1():S1-168. PubMed ID: 23765122
    [No Abstract]   [Full Text] [Related]  

  • 12. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors.
    Jacobus S; Schneeweiss S; Chan KA
    Pharmacoepidemiol Drug Saf; 2004 Oct; 13(10):695-702. PubMed ID: 15386727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in sales of estrogens 1989-1992. Effects of a national consensus conference?].
    Hannestad YS; Hunskår S; Matheson I
    Tidsskr Nor Laegeforen; 1993 Nov; 113(28):3479-82. PubMed ID: 8273080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National observation of prescriptions and consumption and pharmacoepidemiology].
    Bouvenot G
    Therapie; 2000; 55(1):141-2. PubMed ID: 10860016
    [No Abstract]   [Full Text] [Related]  

  • 15. 1st Meeting of EURO DURG, the European Drug Utilization Research Group. Hungary, 27-30 June 1996. Abstracts.
    Eur J Clin Pharmacol; 1997; 52(3):A19-28. PubMed ID: 9273307
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug utilization in Europe--report of the EURO-DURG workshop and joint symposium with the EACPT Berlin 16.9-18.9 1997. European Drug Utilization Research Group. European Association for Clinical Pharmacology and Therapeutics.
    Schubert I
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):176-9. PubMed ID: 9562235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999.
    Stolk P; Egberts AC; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):105-11. PubMed ID: 11998534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstracts of the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. August 23-26, 2012. Barcelona, Spain.
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21 Suppl 3():1-501. PubMed ID: 22926829
    [No Abstract]   [Full Text] [Related]  

  • 19. Abstracts of the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Providence, Rhode Island, USA. August 16-19, 2009.
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18 Suppl 1():S1-273. PubMed ID: 21157870
    [No Abstract]   [Full Text] [Related]  

  • 20. The founding of the EURO-DURG, the European Drug Utilization Research Group.
    Schubert I
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):410-3. PubMed ID: 8880293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.